News for Eagle Pharmaceuticals, Inc. (EGRX)

On December 31, 2024, Union Square Park Capital Management, LLC (Trades, Portfolio) executed a significant transaction involving Eagle Pharmaceuticals Inc (EGRX

WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the

Overview of the Recent Transaction On October 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a significant transaction involving the s

According to a report by Fortune Business Insights, the Vasopressin for Vasoplegic Shock Market size sector reached a market value of USD 890.9 Million in 2019. Future projections show a bright…

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws...

The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of...

Overview of the Recent Transaction On October 3, 2024, Union Square Park Capital Management, LLC (Trades, Portfolio) made a significant move in the pharmaceutic

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 0.2% on Wednesday. The Dow traded up 0.07% to 42,186.44 ...

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 100 points on Wednesday. The Dow traded up 0.24% to 42,256.16 while t...

U.S. stocks traded lower this morning, with the Dow Jones index falling around 0.1% on Wednesday. Following the market opening Wednesday, the Dow traded down 0...

SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws...

As per Fortune Business Insights’ report, the vasopressin for vasoplegic shock Market share sector attained a worth of USD 890.9 Million in 2019. Forecasts indicate a promising path ahead, foreseeing…

Brandes Investment portfolio, holdings, 13F and news. Updated: 2024-06-06

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

EGRX | Complete Eagle Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

• Q4 2022 net income was $0.63 per basic and $0.62 per diluted share and adjusted non-GAAP net income was $1.11 per basic and $1.10 per diluted share1 •...

WOODCLIFF LAKE, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. is re-issuing in its entirety its earnings press release for the...

Q3 2022 net loss was $(0.27) per basic and diluted share and adjusted non-GAAP net income was $1.13 per basic and $1.12 per diluted share1Total...